PURE Bioscience, Inc. (PURE) Total liabilities 2012–2025
PURE Bioscience, Inc. (PURE) total liabilities at each fiscal year-end, per SEC filings.
$6.2MFY2025 · since FY2012: $3.6M → $6.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.2M | +67.7% |
| FY2024 | $3.7M | +137.1% |
| FY2023 | $1.6M | +170.1% |
| FY2022 | $575,000 | -40.7% |
| FY2021 | $970,000 | -35.8% |
| FY2020 | $1.5M | +103.8% |
| FY2019 | $742,000 | -42.7% |
| FY2018 | $1.3M | -49.0% |
| FY2017 | $2.5M | — |
| FY2012 | $3.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice